Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Loa Loa (eye worm) | glutaminase | 0.0298 | 0.5693 | 0.5693 |
Schistosoma mansoni | tar DNA-binding protein | 0.028 | 0.5315 | 0.933 |
Schistosoma mansoni | hypothetical protein | 0.0117 | 0.1888 | 0.325 |
Loa Loa (eye worm) | latrophilin receptor protein 2 | 0.0117 | 0.1888 | 0.1888 |
Brugia malayi | Glycosyl hydrolases family 31 protein | 0.0042 | 0.0301 | 0.0301 |
Echinococcus multilocularis | peptidase Clp (S14 family) | 0.0053 | 0.0534 | 0.0911 |
Echinococcus granulosus | lysosomal alpha glucosidase | 0.0187 | 0.3368 | 0.6298 |
Echinococcus granulosus | peregrin | 0.0033 | 0.0132 | 0.0146 |
Entamoeba histolytica | hypothetical protein | 0.0037 | 0.0202 | 0.6713 |
Echinococcus multilocularis | thyroid hormone receptor alpha | 0.015 | 0.2576 | 0.4793 |
Echinococcus multilocularis | diuretic hormone 44 receptor GPRdih2 | 0.0117 | 0.1888 | 0.3484 |
Trypanosoma brucei | glucosidase, putative | 0.0042 | 0.0301 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.008 | 0.1117 | 0.1117 |
Echinococcus granulosus | ATP dependent Clp protease proteolytic subunit | 0.008 | 0.1117 | 0.2018 |
Echinococcus granulosus | neutral alpha glucosidase AB | 0.0042 | 0.0301 | 0.0468 |
Echinococcus granulosus | lysine specific demethylase 5A | 0.0036 | 0.0187 | 0.0251 |
Schistosoma mansoni | smad | 0.0034 | 0.0147 | 0.0163 |
Echinococcus multilocularis | peregrin | 0.0033 | 0.0132 | 0.0146 |
Schistosoma mansoni | tar DNA-binding protein | 0.028 | 0.5315 | 0.933 |
Schistosoma mansoni | hypothetical protein | 0.0117 | 0.1888 | 0.325 |
Wolbachia endosymbiont of Brugia malayi | ATP-dependent Clp protease proteolytic subunit | 0.008 | 0.1117 | 0.5 |
Schistosoma mansoni | smad1 5 8 and | 0.0034 | 0.0147 | 0.0163 |
Mycobacterium leprae | PROBABLE ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT 1 CLPP1 (ENDOPEPTIDASE CLP) | 0.0053 | 0.0534 | 0.4785 |
Echinococcus multilocularis | lysosomal alpha glucosidase | 0.0187 | 0.3368 | 0.6298 |
Loa Loa (eye worm) | Smad1 | 0.0034 | 0.0147 | 0.0147 |
Chlamydia trachomatis | ATP-dependent Clp protease proteolytic subunit | 0.008 | 0.1117 | 0.5 |
Loa Loa (eye worm) | PHD-finger family protein | 0.003 | 0.0055 | 0.0055 |
Loa Loa (eye worm) | jmjC domain-containing protein | 0.0036 | 0.0187 | 0.0187 |
Brugia malayi | Latrophilin receptor protein 2 | 0.0117 | 0.1888 | 0.1888 |
Echinococcus multilocularis | geminin | 0.0173 | 0.308 | 0.575 |
Echinococcus multilocularis | gcn5proteinral control of amino acid synthesis | 0.0148 | 0.2551 | 0.4745 |
Mycobacterium leprae | PROBABLE ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT 2 CLPP2 (ENDOPEPTIDASE CLP 2) | 0.008 | 0.1117 | 1 |
Echinococcus granulosus | tar DNA binding protein | 0.028 | 0.5315 | 1 |
Echinococcus granulosus | jumonji domain containing protein | 0.0042 | 0.0301 | 0.0468 |
Schistosoma mansoni | thyroid hormone receptor | 0.015 | 0.2576 | 0.4472 |
Plasmodium falciparum | histone acetyltransferase GCN5 | 0.004 | 0.0269 | 0.2347 |
Loa Loa (eye worm) | hypothetical protein | 0.0369 | 0.7205 | 0.7205 |
Mycobacterium leprae | ATP-dependent Clp protease proteolytic subunit 1 | 0.0028 | 0.0009 | 0.0079 |
Echinococcus multilocularis | neutral alpha glucosidase AB | 0.0042 | 0.0301 | 0.0468 |
Echinococcus multilocularis | Basic leucine zipper (bZIP) transcription | 0.0037 | 0.0202 | 0.028 |
Echinococcus multilocularis | TGF beta signal transducer SmadC | 0.0034 | 0.0147 | 0.0175 |
Echinococcus multilocularis | GPCR, family 2 | 0.0117 | 0.1888 | 0.3484 |
Leishmania major | alpha glucosidase II subunit, putative | 0.0042 | 0.0301 | 1 |
Echinococcus multilocularis | tar DNA binding protein | 0.028 | 0.5315 | 1 |
Schistosoma mansoni | alpha-glucosidase | 0.0161 | 0.2819 | 0.4902 |
Schistosoma mansoni | peptidase Clp (S14 family) | 0.008 | 0.1117 | 0.1883 |
Schistosoma mansoni | tar DNA-binding protein | 0.028 | 0.5315 | 0.933 |
Schistosoma mansoni | glutaminase | 0.0298 | 0.5693 | 1 |
Schistosoma mansoni | transcription factor LCR-F1 | 0.0037 | 0.0202 | 0.0261 |
Brugia malayi | Probable ClpP-like protease | 0.008 | 0.1117 | 0.1117 |
Loa Loa (eye worm) | hypothetical protein | 0.0117 | 0.1888 | 0.1888 |
Brugia malayi | Bromodomain containing protein | 0.0033 | 0.0132 | 0.0132 |
Brugia malayi | hypothetical protein | 0.0037 | 0.0202 | 0.0202 |
Echinococcus granulosus | Smad4 | 0.0034 | 0.0147 | 0.0175 |
Echinococcus granulosus | Mitotic checkpoint protein PRCC C terminal | 0.0129 | 0.2141 | 0.3965 |
Entamoeba histolytica | acetyltransferase, GNAT family | 0.004 | 0.0269 | 0.8929 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.0369 | 0.7205 | 0.7205 |
Echinococcus granulosus | peptidase Clp S14 family | 0.0053 | 0.0534 | 0.0911 |
Mycobacterium tuberculosis | Probable ATP-dependent CLP protease proteolytic subunit 2 ClpP2 (endopeptidase CLP 2) | 0.0053 | 0.0534 | 1 |
Schistosoma mansoni | alpha glucosidase | 0.0042 | 0.0301 | 0.0436 |
Loa Loa (eye worm) | transcription factor SMAD2 | 0.0502 | 1 | 1 |
Brugia malayi | RNA binding protein | 0.028 | 0.5315 | 0.5315 |
Echinococcus multilocularis | lysine specific demethylase 5A | 0.0036 | 0.0187 | 0.0251 |
Brugia malayi | MH1 domain containing protein | 0.0034 | 0.0147 | 0.0147 |
Toxoplasma gondii | histone lysine acetyltransferase GCN5-B | 0.0044 | 0.0345 | 0.3038 |
Loa Loa (eye worm) | hypothetical protein | 0.0051 | 0.0504 | 0.0504 |
Loa Loa (eye worm) | hypothetical protein | 0.003 | 0.0055 | 0.0055 |
Schistosoma mansoni | jumonji domain containing protein | 0.0078 | 0.1062 | 0.1786 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0042 | 0.0301 | 0.5 |
Brugia malayi | calcium-independent alpha-latrotoxin receptor 2, putative | 0.0117 | 0.1888 | 0.1888 |
Loa Loa (eye worm) | MH2 domain-containing protein | 0.0502 | 1 | 1 |
Mycobacterium ulcerans | ATP-dependent Clp protease proteolytic subunit | 0.008 | 0.1117 | 0.1962 |
Brugia malayi | MH2 domain containing protein | 0.0034 | 0.0147 | 0.0147 |
Loa Loa (eye worm) | RNA recognition domain-containing protein domain-containing protein | 0.028 | 0.5315 | 0.5315 |
Loa Loa (eye worm) | MH2 domain-containing protein | 0.0034 | 0.0147 | 0.0147 |
Echinococcus granulosus | muscleblind protein | 0.0153 | 0.2647 | 0.4927 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0042 | 0.0301 | 0.5 |
Brugia malayi | glutaminase DH11.1 | 0.0298 | 0.5693 | 0.5693 |
Loa Loa (eye worm) | glycosyl hydrolase family 31 protein | 0.0187 | 0.3368 | 0.3368 |
Loa Loa (eye worm) | RNA binding protein | 0.028 | 0.5315 | 0.5315 |
Echinococcus multilocularis | Smad4 | 0.0034 | 0.0147 | 0.0175 |
Echinococcus multilocularis | Mitotic checkpoint protein PRCC, C terminal | 0.0129 | 0.2141 | 0.3965 |
Onchocerca volvulus | Alhambra homolog | 0.003 | 0.0055 | 0.0322 |
Loa Loa (eye worm) | acetyltransferase | 0.0148 | 0.2551 | 0.2551 |
Brugia malayi | Muscleblind-like protein | 0.0153 | 0.2647 | 0.2647 |
Plasmodium falciparum | phd finger protein, putative | 0.003 | 0.0055 | 0.0417 |
Echinococcus multilocularis | cadherin EGF LAG seven pass G type receptor | 0.0117 | 0.1888 | 0.3484 |
Loa Loa (eye worm) | glutaminase 2 | 0.0298 | 0.5693 | 0.5693 |
Echinococcus granulosus | TGF beta signal transducer SmadC | 0.0034 | 0.0147 | 0.0175 |
Echinococcus granulosus | geminin | 0.0173 | 0.308 | 0.575 |
Brugia malayi | PHD-finger family protein | 0.003 | 0.0055 | 0.0055 |
Brugia malayi | jmjC domain containing protein | 0.0036 | 0.0187 | 0.0187 |
Plasmodium vivax | histone acetyltransferase GCN5, putative | 0.0044 | 0.0345 | 0.3038 |
Echinococcus granulosus | diuretic hormone 44 receptor GPRdih2 | 0.0117 | 0.1888 | 0.3484 |
Echinococcus granulosus | GPCR family 2 | 0.0117 | 0.1888 | 0.3484 |
Brugia malayi | Smad1 | 0.0034 | 0.0147 | 0.0147 |
Echinococcus granulosus | Transcription factor JmjC domain containing protein | 0.0098 | 0.1485 | 0.2719 |
Schistosoma mansoni | hypothetical protein | 0.0173 | 0.308 | 0.5365 |
Entamoeba histolytica | hypothetical protein | 0.0037 | 0.0202 | 0.6713 |
Loa Loa (eye worm) | TAR-binding protein | 0.028 | 0.5315 | 0.5315 |
Echinococcus multilocularis | lysosomal alpha glucosidase | 0.0187 | 0.3368 | 0.6298 |
Echinococcus multilocularis | Transcription factor, JmjC domain containing protein | 0.0098 | 0.1485 | 0.2719 |
Schistosoma mansoni | Smad4 | 0.0034 | 0.0147 | 0.0163 |
Brugia malayi | jmjC domain containing protein | 0.0098 | 0.1485 | 0.1485 |
Echinococcus multilocularis | ATP dependent Clp protease proteolytic subunit | 0.008 | 0.1117 | 0.2018 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.0369 | 0.7205 | 0.7205 |
Echinococcus granulosus | mothers against decapentaplegic 5 | 0.0034 | 0.0147 | 0.0175 |
Schistosoma mansoni | smad1 5 8 and | 0.0034 | 0.0147 | 0.0163 |
Trichomonas vaginalis | glutaminase, putative | 0.0298 | 0.5693 | 1 |
Brugia malayi | RNA recognition motif domain containing protein | 0.028 | 0.5315 | 0.5315 |
Brugia malayi | MH1 domain containing protein | 0.0034 | 0.0147 | 0.0147 |
Schistosoma mansoni | gcn5proteinral control of amino-acid synthesis 5-like 2 gcnl2 | 0.0148 | 0.2551 | 0.4427 |
Echinococcus multilocularis | jumonji domain containing protein | 0.0042 | 0.0301 | 0.0468 |
Loa Loa (eye worm) | MH1 domain-containing protein | 0.0034 | 0.0147 | 0.0147 |
Schistosoma mansoni | tar DNA-binding protein | 0.028 | 0.5315 | 0.933 |
Trichomonas vaginalis | bromodomain-containing protein, putative | 0.0044 | 0.0345 | 0.0082 |
Echinococcus granulosus | cadherin EGF LAG seven pass G type receptor | 0.0117 | 0.1888 | 0.3484 |
Toxoplasma gondii | histone lysine acetyltransferase GCN5-A | 0.0044 | 0.0345 | 0.3038 |
Echinococcus granulosus | histone acetyltransferase KAT2B | 0.0144 | 0.2464 | 0.4579 |
Schistosoma mansoni | jumonji/arid domain-containing protein | 0.0036 | 0.0187 | 0.0235 |
Schistosoma mansoni | thyroid hormone receptor | 0.015 | 0.2576 | 0.4472 |
Echinococcus multilocularis | muscleblind protein 1 | 0.0153 | 0.2647 | 0.4927 |
Plasmodium falciparum | ATP-dependent Clp protease proteolytic subunit | 0.008 | 0.1117 | 1 |
Echinococcus granulosus | Basic leucine zipper bZIP transcription | 0.0037 | 0.0202 | 0.028 |
Toxoplasma gondii | ATP-dependent Clp endopeptidase, proteolytic subunit ClpP domain-containing protein | 0.008 | 0.1117 | 1 |
Echinococcus granulosus | smad | 0.0034 | 0.0147 | 0.0175 |
Schistosoma mansoni | hypothetical protein | 0.0117 | 0.1888 | 0.325 |
Entamoeba histolytica | hypothetical protein | 0.0037 | 0.0202 | 0.6713 |
Brugia malayi | latrophilin 2 splice variant baaae | 0.0253 | 0.4744 | 0.4744 |
Echinococcus granulosus | histone acetyltransferase KAT2B | 0.0044 | 0.0345 | 0.0552 |
Plasmodium vivax | ATP-dependent Clp protease proteolytic subunit, putative | 0.008 | 0.1117 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0153 | 0.2647 | 0.2647 |
Giardia lamblia | Histone acetyltransferase GCN5 | 0.004 | 0.0269 | 1 |
Toxoplasma gondii | PHD-finger domain-containing protein | 0.003 | 0.0055 | 0.0417 |
Schistosoma mansoni | alpha-glucosidase | 0.0161 | 0.2819 | 0.4902 |
Mycobacterium tuberculosis | Probable ATP-dependent CLP protease proteolytic subunit 1 ClpP1 (endopeptidase CLP) | 0.0053 | 0.0534 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0153 | 0.2647 | 0.2647 |
Loa Loa (eye worm) | glycosyl hydrolase family 31 protein | 0.0042 | 0.0301 | 0.0301 |
Loa Loa (eye worm) | jmjC domain-containing protein | 0.0062 | 0.0724 | 0.0724 |
Echinococcus multilocularis | mothers against decapentaplegic 5 | 0.0034 | 0.0147 | 0.0175 |
Entamoeba histolytica | glycosyl hydrolase, family 31 protein | 0.0042 | 0.0301 | 1 |
Schistosoma mansoni | jumonji/arid domain-containing protein | 0.0036 | 0.0187 | 0.0235 |
Mycobacterium ulcerans | ATP-dependent Clp protease proteolytic subunit | 0.008 | 0.1117 | 0.1962 |
Schistosoma mansoni | smad1 5 8 and | 0.0034 | 0.0147 | 0.0163 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.0369 | 0.7205 | 0.7205 |
Brugia malayi | MH2 domain containing protein | 0.0034 | 0.0147 | 0.0147 |
Loa Loa (eye worm) | hypothetical protein | 0.0253 | 0.4744 | 0.4744 |
Entamoeba histolytica | glycosyl hydrolase, family 31 protein | 0.0042 | 0.0301 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0117 | 0.1888 | 0.325 |
Schistosoma mansoni | hypothetical protein | 0.0253 | 0.4744 | 0.8316 |
Toxoplasma gondii | PHD-finger domain-containing protein | 0.003 | 0.0055 | 0.0417 |
Onchocerca volvulus | 0.0108 | 0.1706 | 1 | |
Entamoeba histolytica | hypothetical protein | 0.0037 | 0.0202 | 0.6713 |
Brugia malayi | Glycosyl hydrolases family 31 protein | 0.0187 | 0.3368 | 0.3368 |
Schistosoma mansoni | hypothetical protein | 0.0037 | 0.0202 | 0.0261 |
Chlamydia trachomatis | ATP-dependent Clp protease proteolytic subunit | 0.008 | 0.1117 | 0.5 |
Mycobacterium ulcerans | glutaminase | 0.0298 | 0.5693 | 1 |
Echinococcus multilocularis | muscleblind protein | 0.0153 | 0.2647 | 0.4927 |
Brugia malayi | acetyltransferase, GNAT family protein | 0.0148 | 0.2551 | 0.2551 |
Schistosoma mansoni | TGF-beta signal transducer Smad2 | 0.0034 | 0.0147 | 0.0163 |
Plasmodium vivax | hypothetical protein, conserved | 0.003 | 0.0055 | 0.0417 |
Schistosoma mansoni | hypothetical protein | 0.0173 | 0.308 | 0.5365 |
Toxoplasma gondii | glycosyl hydrolase, family 31 protein | 0.0042 | 0.0301 | 0.2638 |
Brugia malayi | TAR-binding protein | 0.028 | 0.5315 | 0.5315 |
Schistosoma mansoni | tar DNA-binding protein | 0.028 | 0.5315 | 0.933 |
Trichomonas vaginalis | cat eye syndrome critical region protein 2, cscr2, putative | 0.0044 | 0.0345 | 0.0082 |
Treponema pallidum | ATP-dependent Clp protease proteolytic subunit | 0.008 | 0.1117 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0129 | 0.2141 | 0.3699 |
Echinococcus multilocularis | smad | 0.0034 | 0.0147 | 0.0175 |
Toxoplasma gondii | ATP-dependent Clp endopeptidase, proteolytic subunit ClpP domain-containing protein | 0.008 | 0.1117 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Block (functional) | = 30 % | Percentage block of the hind-limb tonic-extensor seizure was determined after application of an electric shock to mice for 30 min followed by 200 mg/kg peroral dose | ChEMBL. | 3572976 |
Block (functional) | = 30 % | Percentage block of the hind-limb tonic-extensor seizure was determined after application of an electric shock to mice for 30 min followed by 100 mg/kg intraperitoneal dose | ChEMBL. | 3572976 |
Block (functional) | = 30 % | Percentage block of the hind-limb tonic-extensor seizure was determined after application of an electric shock to mice for 60 min followed by 100 mg/kg intraperitoneal dose | ChEMBL. | 3572976 |
Block (functional) | = 30 % | Percentage block of the hind-limb tonic-extensor seizure was determined after application of an electric shock to mice for 240 min followed by 100 mg/kg intraperitoneal dose | ChEMBL. | 3572976 |
Block (functional) | = 30 % | Percentage block of the hind-limb tonic-extensor seizure was determined after application of an electric shock to mice for 30 min followed by 200 mg/kg peroral dose | ChEMBL. | 3572976 |
Block (functional) | = 30 % | Percentage block of the hind-limb tonic-extensor seizure was determined after application of an electric shock to mice for 30 min followed by 100 mg/kg intraperitoneal dose | ChEMBL. | 3572976 |
Block (functional) | = 30 % | Percentage block of the hind-limb tonic-extensor seizure was determined after application of an electric shock to mice for 60 min followed by 100 mg/kg intraperitoneal dose | ChEMBL. | 3572976 |
Block (functional) | = 30 % | Percentage block of the hind-limb tonic-extensor seizure was determined after application of an electric shock to mice for 240 min followed by 100 mg/kg intraperitoneal dose | ChEMBL. | 3572976 |
Block (functional) | = 40 % | Percentage block of the hind-limb tonic-extensor seizure was determined after application of an electric shock to mice for 60 min followed by 200 mg/kg peroral dose | ChEMBL. | 3572976 |
Block (functional) | = 40 % | Percentage block of the hind-limb tonic-extensor seizure was determined after application of an electric shock to mice for 60 min followed by 200 mg/kg peroral dose | ChEMBL. | 3572976 |
Block (functional) | = 50 % | Percentage block of the hind-limb tonic-extensor seizure was determined after application of an electric shock to mice for 120 min followed by 100 mg/kg intraperitoneal dose | ChEMBL. | 3572976 |
Block (functional) | = 50 % | Percentage block of the hind-limb tonic-extensor seizure was determined after application of an electric shock to mice for 120 min followed by 100 mg/kg intraperitoneal dose | ChEMBL. | 3572976 |
Block (functional) | = 80 % | Percentage block of the hind-limb tonic-extensor seizure was determined after application of an electric shock to mice for 120 min followed by 200 mg/kg peroral dose | ChEMBL. | 3572976 |
Block (functional) | = 80 % | Percentage block of the hind-limb tonic-extensor seizure was determined after application of an electric shock to mice for 240 min followed by 200 mg/kg peroral dose | ChEMBL. | 3572976 |
Block (functional) | = 80 % | Percentage block of the hind-limb tonic-extensor seizure was determined after application of an electric shock to mice for 120 min followed by 200 mg/kg peroral dose | ChEMBL. | 3572976 |
Block (functional) | = 80 % | Percentage block of the hind-limb tonic-extensor seizure was determined after application of an electric shock to mice for 240 min followed by 200 mg/kg peroral dose | ChEMBL. | 3572976 |
ED50 (functional) | > 100 mg kg-1 | Anticonvulsant activity of the compound was determined by using a standard maximal electroshock test (MES) in mice, by intraperitoneal administration of the compound | ChEMBL. | 3572976 |
ED50 (functional) | > 100 mg kg-1 | Anticonvulsant activity of the compound was determined by using a standard maximal electroshock test (MES) in mice, by intraperitoneal administration of the compound | ChEMBL. | 3572976 |
ED50 (functional) | > 200 mg kg-1 | Anticonvulsant activity following p.o. administration by standard maximal electroshock test in mice. | ChEMBL. | 3572976 |
ED50 (functional) | > 200 mg kg-1 | Anticonvulsant activity following p.o. administration by standard maximal electroshock test in mice. | ChEMBL. | 3572976 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.